According to the Zhitong Finance App, Sanai Health Group (01889) announced its 2023 annual results, with revenue of about 122 million yuan (RMB, same below); a year-on-year decrease of about 30.59%; profit attributable to company owners was 18.633 million yuan, a year-on-year decrease of 36.23%; profit per share was 0.58 points.
According to reports, the decline in earnings was mainly due to a decrease in sales of self-produced pharmaceutical products and sales of pharmaceutical products from other non-competitive pharmaceutical companies.